InSite (Seller)Bess Royalty (Buyer)SWK Holdings (Buyer)
Bess Royalty and SWK Funding purchased InSite's royalties on sales of Besivance besifloxacin ophthalmic solution for up to $16 million
Pfizer (Other)Bausch + Lomb (Other)
Pfizer and Bausch + Lomb are partnering to co-promote other's ophthalmic drugs in the U.S.
Set Email Alert